Delivery Order SPE2DB20D1100-SPE2DB24FD0Z4

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $100,636.46, is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.76 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine, to support defense medical requirements. The contract has a completion date of June 4, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX VACCINE SYRINGEml, a hepatitis A and hepatitis B vaccine, with a ceiling value of $1,078.23 and a period of performance through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This contract award, valued at $26,997.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine used to prevent hepatitis A and hepatitis B. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 5, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a large Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of TWINRIX Vaccine syringes, a vaccine used for the prevention of hepatitis A and hepatitis B. The contract has a ceiling value of $2,705.52 and runs through February 8, 2024. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and B vaccine, at a ceiling value of $1,481.68. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,882.20, is for the delivery of TWINRIX VACCINE SYRINGEML and has a completion date of May 24, 2024. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TWINRIX VACCINE SYRINGEML, with a total ceiling value of $18,029.10. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 25, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $14,477.01, is for the supply of the TWINRIX vaccine, a combination hepatitis A and hepatitis B vaccine, to support federal healthcare programs. The Firm Fixed Price contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,818.87 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD0Z4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $20,282.40 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGE ML, a combination vaccine used to prevent hepatitis A and hepatitis B. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued at up to $999,999,999 and $750,000 respectively, that serve as primary vehicles for providing a wide range of medical commodities to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives. This contract award does not have a set-aside designation.

Generated 11/4/24, 12:07 PM